Skip to content

Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy

Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04738500
Enrollment
60
Registered
2021-02-04
Start date
2021-04-15
Completion date
2021-06-15
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Pericapsular nerve group block (PENG) has been deemed as a safe and effective regional technique for postoperative pain after knee arthroscopy.

Detailed description

Pericapsular nerve group block(PENG) has been deemed as a safe and effective regional technique for postoperative pain after knee artroscopy. Blockade of the branches of the femoral and obturator nerves that provide innervation to any structures distal enough to be useful in knee.

Interventions

PROCEDUREPENG Block combinated with PCA

After spinal anesthesia PENG block will be performed

PROCEDUREPCA

PCA will be applied after surgery

Sponsors

Bora Bilal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients agreed to receive PENG block * Knee arthroscopy

Exclusion criteria

* Other kinds of knee surgery * Patients refuse to receive PENG block

Design outcomes

Primary

MeasureTime frameDescription
First analgesic demand24 HoursThe time interval from PENG blocks to the first analgesic demand.

Secondary

MeasureTime frameDescription
Opioid consumption24 HoursTotal opioid analgesic consumption
Numeric Rating Scale24 HoursThe maximum score on a 10cm numeric rating scale: (0 to 10cm) (0 = no pain, 10 = worst imaginable pain)

Countries

Turkey (Türkiye)

Contacts

Primary ContactBora Bilal, Assos. Prof.
bilalbora@yahoo.com05052354430

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026